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The S phase-specific adaptor protein Claspin mediates the checkpoint response to replication stress by facilitating
phosphorylation of Chk1 by ataxia-telangiectasia and Rad3-related (ATR). Evidence suggests that these components of the
ATR pathway also play a critical role during physiological S phase. Chk1 is required for high rates of global replication
fork progression, and Claspin interacts with the replication machinery and might therefore monitor normal DNA
replication. Here, we have used DNA fiber labeling to investigate, for the first time, whether human Claspin is required
for high rates of replication fork progression during normal S phase. We report that Claspin-depleted HeLa and HCT116
cells display levels of replication fork slowing similar to those observed in Chk1-depleted cells. This was also true in
primary human 1BR3 fibroblasts, albeit to a lesser extent, suggesting that Claspin is a universal requirement for high
replication fork rates in human cells. Interestingly, Claspin-depleted cells retained significant levels of Chk1 phosphor-
ylation at both Ser317 and Ser345, raising the possibility that Claspin function during normal fork progression may extend
beyond facilitating phosphorylation of either individual residue. Consistent with this possibility, depletion of Chk1 and
Claspin together doubled the percentage of very slow forks, compared with depletion of either protein alone.
INTRODUCTION
Dividing cells are constantly challenged with DNA damage
and other difficult conditions for DNA replication and chro-
mosome segregation. DNA damage response pathways
maintain genomic integrity by coordinating the regulation
of cell cycle progression with DNA repair. During S phase,
replication fork progression can be impaired by insufficient
nucleotide supply or lesions and obstacles on the DNA
template. This activates the DNA damage sensor kinase
ataxia-telangiectasia and Rad3-related (ATR), which acti-
vates its major downstream effector kinase Chk1 by phos-
phorylation on the serine residues Ser317 and Ser345 (Liu
et al., 2000; Zhao and Piwnica-Worms, 2001). Together, ATR
and Chk1 suppress further origin firing and stabilize stalled
replication forks. The ATR-Chk1 pathway is vital even in the
absence of exogenous stresses, during an “unperturbed” cell
cycle (Petermann and Caldecott, 2006). Our own findings
demonstrate that Chk1 is required for high rates of replica-
tion fork progression during an unperturbed S phase (Pe-
termann et al., 2006), and we and others have shown that
inhibition or depletion of Chk1 in human cells leads to
increased origin firing, accumulation of single-stranded
DNA (Syljuasen et al., 2005; Maya-Mendoza et al., 2007),
activation of the ATR pathway and the generation of DNA
breaks (Syljuasen et al., 2005).
ATR depends on the S/G2 phase-specific adaptor protein
Claspin to efficiently phosphorylate Chk1 in Xenopus and
several human cell lines (Kumagai and Dunphy, 2000; Chini
and Chen, 2003; Lin et al., 2004; Chini et al., 2006; Liu et al.,
2006). Human Claspin is constitutively associated with ATR,
and phosphorylation of Claspin, presumably by ATR, facil-
itates its interaction with Chk1 (Chini and Chen, 2003). This
interaction with Chk1, which occurs via the active site of
Chk1, is required for the promotion of Chk1 phosphoryla-
tion (Lee et al., 2005). Chk1, in turn, stabilizes Claspin in
HeLa cells (Chini et al., 2006). There is evidence for a role of
Claspin during normal DNA replication. Claspin is a ring-
shaped protein that binds to replication fork structures (Sar
et al., 2004). Xenopus Claspin binds to chromatin in a pre-
replicative complex (RC) and Cdc45-dependent manner,
suggesting binding to origins during unwinding, and it
interacts with several replication proteins, including RPA,
RFC, and Cdc45 (Lee et al., 2003, 2005). Depletion of Claspin
from Xenopus egg extracts leads to modestly reduced DNA
synthesis rates in vitro (Lee et al., 2003). In human cells,
overexpression or small interfering RNA (siRNA)-mediated
depletion of Claspin increases or reduces, respectively, cell
proliferation and the percentage of 5-bromo-2-deoxyuri-
dine (BrdU)-positive cells (Lin et al., 2004). Similar to deple-
tion of Chk1, depletion of human Claspin induces DNA
damage (Liu et al., 2006). Finally, Mrc1, the functional
homologue of Claspin in Saccharomyces cerevisiae, travels
with the replication fork (Osborn and Elledge, 2003), and
it is required for normal fork progression rates during un-
perturbed S phase. Replication forks in Mrc1 cells progress
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at 50–70% of the normal rate (Szyjka et al., 2005; Tourriere
et al., 2005; Hodgson et al., 2007).
Here, we have used DNA fiber labeling to examine, for the
first time, whether Claspin is required for normal replication
fork progression rates in human cells. We conclude that
Claspin is required for high rates of fork progression during
normal human S phase, and we suggest that this requirement
may extend beyond the reported role of Claspin in mediating
the phosphorylation of Chk1 at Ser317 and Ser345.
MATERIALS AND METHODS
Cell Lines
Human HeLa adenocarcinoma cells were grown in RPMI 1640 medium
supplemented with 10% fetal calf serum (FCS), human HCT116 colon carci-
noma cells were grown in DMEM supplemented with 10% FCS, and 1BR3
primary human fibroblasts were grown in minimal essential medium supple-
mented with 15% FCS. All cell lines were grown in a humidified CO2
atmosphere at 37°C.
DNA Fiber Experiments
To knock down human Claspin, we used an siRNA duplex oligonucleotide
(QIAGEN, Hilden, Germany) directed against the Claspin target sequence
(sense): CCUUGCUUAGAGCUGAGUC (Chini et al., 2006). To knock down
human Chk1, we used siRNA duplex oligonucleotides (Invitrogen, Paisley,
United Kingdom) directed against the Chk1 target sequence (sense) UCGU-
GAGCGUUUGUUGAAC (Zhu et al., 2004). siRNA duplex oligonucleotides
directed against the firefly luciferase target sequence CUUACGCU-
GAGUACUUCGA (Hoek and Stillman, 2003) were used as a control. siRNA
duplexes (10 nM) were transfected using siPORT NeoFX reverse transfection
reagent (Ambion, Austin, TX) (0.25 l reagent/104 cells, at a cell concentration
of 1 105/ml). 1BR3 cells were transfected with 50 nM siRNA duplex and 1.2
l of reagent/104 cells, at a cell concentration of 2.5  104/ml.
Twenty-four hours after siRNA transfection (or 48 h after transfection for
1BR3 cells), exponentially growing cells were pulse labeled with 25 M BrdU
for 15 min followed by 250 M iododeoxyuridine (IdU) for 20 min, as
indicated. Labeled cells were harvested, and DNA fiber spreads prepared as
described previously (Petermann et al., 2006). For immunodetection of BrdU-
labeled tracts, acid treated fiber spreads were incubated with rat anti-BrdU
monoclonal antibody (mAb) (Oxford Biotechnology, Oxon, United Kingdom)
at 1:600 dilution for 1 h at room temperature. Slides were then fixed with 4%
paraformaldehyde and incubated with an AlexaFluor 488-conjugated donkey
anti-rat immunoglobulin G (IgG) (Invitrogen) at 4 g/ml for 1.5 h at room
temperature. To detect both BrdU- and IdU-labeled patches, a mouse mAb
that recognizes both IdU and BrdU (BD Biosciences, Franklin Lakes, NJ) was
used at 17 ng/ml over night at 4°C, followed by an AlexaFluor 555-conjugated
goat anti-mouse IgG (Invitrogen) at 4 g/ml for 1.5 h at room temperature.
Fibers were examined with an LSM 510 confocal microscope (Carl Zeiss, Jena,
Germany) using a 100 (1.4 numerical aperture) lens. The lengths of BrdU-
(Alexa Fluor [AF] 488, green) and IdU (AF 555, red)-labeled patches were
measured using the LSM software (Carl Zeiss), and micrometer values were
converted into kilobase using the conversion factor 1 m  2.59 kb (Henry-
Mowatt et al., 2003). Measurements were recorded from fibers in well spread
(untangled) areas of the slides to prevent the possibility of recording labeled
patches from bundles of fibers.
Immunoblotting
Cells were transfected with 20 nM Claspin siRNA or ON-TARGETplus
siCONTROL Nontargeting Pool (Dharmacon RNA Technologies, Lafayette,
CO) as a control using Dharmafect 1 transfection reagent (Dharamcon RNA
Technologies) (0.6 l reagent/104 cells, at a cell concentration of 5  104/ml).
Forty hours after transfection, cells were treated with 10 mM hydroxyurea
(HU) for the times indicated. Afterward, cells were lysed in radioimmuno-
precipitation assay (RIPA) buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1%
Nonidet P-40, 5% Na-deoxycholate, and 0.1% SDS) containing 1 protease
inhibitor cocktail (Roche Diagnostics, Basel, Switzerland) and 1 phosphatase
inhibitor cocktail 2 (Sigma-Aldrich, Poole, Dorset, United Kingdom). Lysates
from 5.6  104 cells per lane were resolved by SDS-polyacrylamide gel
electrophoresis and transferred to nitrocellulose. Total Claspin was detected
using a rabbit polyclonal anti-Claspin antibody, a kind gift from Dr. Junjie
Chen (Yale School of Medicine, New Haven, CT), at a 1:1000 dilution. Total
Chk1 was detected using rabbit polyclonal anti-Chk1 antibody (Cell Signaling
Technology, Danvers, MA) at a dilution of 1:300. Chk1 phosphorylated at
Ser345 or Ser317 was detected using rabbit polyclonal anti-phospho-Ser345 or
rabbit polyclonal anti-phospho-Ser317 antibody at a dilution of 1:300 (Cell
Signaling Technology). All incubations with primary antibodies were per-
formed at 4°C overnight. Band intensities were quantified by densitometry by
using the ImageJ software (http://rsb.info.nih.gov/ij/).
RESULTS
HeLa cells were transfected with siRNA duplexes directed
against human Claspin or human Chk1, or against luciferase
as a control (Figure 1A). Twenty-four hours later, the cells
were pulse labeled for 15 min with 25 M BrdU followed by
Figure 1. Comparison of replication fibers
and fork rates in HeLa cells depleted of
Claspin and Chk1. (A) Claspin, Chk1, and
XRCC1 (control) levels in total cell extract
from HeLa cells treated with luciferase (con-
trol), Claspin, or Chk1 siRNA for 24 h. (B)
Representative images of replication tracts
from control (luciferase)-, Claspin-, or Chk1-
depleted HeLa cells pulse labeled with 25 M
BrdU for 15 min (green track) followed by 250
M IdU for 20 min (red track), and then pro-
cessed for DNA fiber spreads as described in
Materials and Methods. Fork direction is indi-
cated by a black arrow and the junction be-
tween pulse labels is indicated by white ar-
rows. (C) Distribution of replication fork rates in
control- or Claspin-depleted HeLa cells pulse
labeled and processed as described above. (D)
Distribution of replication fork rates in Chk1- or
Claspin-depleted HeLa cells. For each panel, the
distribution of fork rates during the entire label-
ing period is shown. Data bars are the mean of
three independent experiments, with similar re-
sults observed in each, and error bars represent
1 SD. The total number of forks scored for each
is indicated in parentheses.
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250 M IdU for 20 min, and the length of the labeled DNA
replication tracts in DNA fiber spreads was then quantified
by immunofluorescence. A visual comparison of DNA fibers
from control- and Claspin siRNA-transfected cells revealed
a striking difference in the overall length of their replication
tracts (Figure 1B). When the distribution of fork rates within
populations of forks was quantified and plotted, the entire
distribution of fork rates in Claspin-depleted cells shifted
leftward, to slower fork rates, during both pulse labels (Fig-
ure 1C). The extent of this leftward shift was the same in
Claspin- and Chk1-depleted cells (Figure 1D). Mean fork
rates obtained from these experiments are listed in Table 1.
These data suggest that in Claspin-depleted cells, as in
Chk1-depleted cells, replication forks progress at a slower
rate than in wild-type cells.
We next examined whether Claspin and Chk1 were also
required for high rates of replication fork progression in a
different human cancer cell line, HCT116 colon carcinoma
cells. HCT116 cells were mock transfected or transfected
with Claspin or Chk1 siRNA (Figure 2A). Twenty-four
hours later, cells were pulse labeled as described above, and
fork rate distributions were quantified and plotted. Claspin
depletion strongly reduced overall fork progression rates in
HCT116 cells (Figure 2B). The reduction in fork rates was
slightly more pronounced in Claspin- compared with Chk1-
depleted HCT116 cells (Figure 2C and Table 1), which might
be due to the very efficient depletion of Claspin in this cell
line (Figure 2A).
Both HeLa and HCT116 cells are cancer cell lines; there-
fore, they might have altered checkpoint pathways and rep-
lication machineries as a part or result of tumorigenesis. We
therefore analyzed whether Claspin and Chk1 are also re-
quired for the maintenance of high rates of replication fork
progression in primary human cells. 1BR3 primary human
fibroblasts were control transfected or transfected with
Claspin or Chk1 siRNA duplexes (Figure 3A). Forty-eight
hours later, cells were pulse labeled as described above, and
fork rate distributions were quantified and plotted. Claspin
depletion had a very mild effect on overall fork progression
rates in 1BR3 cells (Figure 3B). This reduction in fork rates
was slightly more pronounced in Chk1-depleted cells than
in Claspin-depleted 1BR3 cells (Figure 3C and Table 1).
These data suggest that both Claspin and Chk1 are required
for high rates of replication fork progression in many human
cell lines, including primary cells, although the requirement
is less pronounced in primary fibroblasts. The requirement
for Claspin and Chk1 is regardless of p53 status, because
both HCT116 and 1BR3 cells are proficient in p53, whereas
HeLa cells are p53 deficient.
Claspin was first described as a mediator of Chk1 phos-
phorylation by ATR, and the similar phenotypes of Claspin-
and Chk1-depleted cells might arise because Claspin func-
tions upstream of Chk1, facilitating its phosphorylation by
ATR. We therefore analyzed whether replication stress-in-
duced phosphorylation of Chk1 was impaired in Claspin-
depleted cells. HeLa or HCT116 cells were transfected with
Claspin or control siRNA and 40 h after transfection, cells
were treated with HU for 1–6 h (Figure 4). Phosphorylation
of Chk1 was analyzed by immunoblotting using specific
Table 1. Comparison of mean fork rates in control-, Claspin-, or
Chk1-siRNA–treated human cell lines
siRNA
Mean fork rates in kb/min (1 SD)
HeLa HCT116 1BR3
Control 0.81 (0.09) 0.98 (0.03) 0.73 (0.02)
Claspin 0.60 (0.08) 0.66 (0.02) 0.63 (0.08)
Chk1 0.63 (0.04) 0.78 (0.08) 0.57 (0.02)
Claspin  Chk1 0.49 (0.07) N.D.a N.D.
Claspin- or Chk1-depleted cells were pulse labeled with 25 M
BrdU for 15 min followed by 250  M IdU for 20 min, and then they
were processed for DNA fiber spreads. Replication fork rates were
measured and the mean fork rates were calculated. Data are com-
bined from two independent experiments or three independent
experiments for HeLa cells.
a N.D., not determined.
Figure 2. Replication fork rates in HCT116 cells depleted of
Claspin and Chk1. (A) Claspin, Chk1, and actin levels in total cell
extract from HCT116 (p53/) cells mock treated or treated with
Chk1 or Claspin siRNA for 24 h. (B) Distribution of replication fork
rates in control- or Claspin-depleted HCT116 cells pulse labeled and
processed as described above. (C) Distribution of replication fork
rates in Chk1- or Claspin-depleted HCT116 cells. For each panel, the
distribution of fork rates during the entire labeling period is shown.
Data are combined from two independent experiments. In one
experiment, mock transfection was used as a control, and in the
other experiment, cells were treated with luciferase siRNA as con-
trol. For each data set, the similar results were observed in each
experimental repeat. The total number of forks scored for each cell
line is indicated in parentheses.
Claspin Is Required for Replication
Vol. 19, June 2008 2375
antibodies directed against Chk1 phosphorylated on Ser317
or Ser345 (Figure 4). Claspin depletion decreased phosphor-
ylation of Chk1 at Ser317 and Ser345 in both HeLa (Figure
4A) and HCT116 cells (Figure 4B). Phosphorylation at Ser317
was decreased by 50% and phosphorylation at Ser345 was
decreased by up to 70% in Claspin-depleted cells. In agree-
ment with observations by Chini et al. (2006), we observed
decreased hyperphosphorylation of Chk1 in Claspin-de-
pleted cells (Figure 4, A and B, supershifted bands indicated
by arrows with asterisks). Thus, Claspin depletion has a
greater impact on phosphorylation of Chk1 at Ser345 than at
Ser317, which is in good agreement with observations in
U2OS cells (Liu et al., 2006), but significant phosphorylation
at both sites remains in Claspin-depleted cells.
To analyze further the relationship between Claspin and
Chk1 during normal replication fork progression, we co-
transfected HeLa cells with Claspin and Chk1 siRNA to
knock down both proteins simultaneously (Figure 5A).
Comparison of the fork rate distributions between Claspin
only- and Claspin- and Chk1-depleted cells revealed that
simultaneous knockdown of both proteins increased the
percentage of very slow-progressing forks (400 base pairs/
min) about twofold (Figure 5B). A comparison of fork rate
distributions between Chk1- and double-depleted cells
yielded the same result (Figure 5C). Quantification of deple-
tion efficiencies for Claspin and Chk1 confirmed that this
increase in very slow forks was not due to more efficient
depletion of either protein in double-depleted samples (Fig-
ure 5A). These data are consistent with Claspin and Chk1
fulfilling distinct, but partially overlapping, roles during the
maintenance of normal replication fork rates.
DISCUSSION
Here, we report that Claspin is required for normal rates
of replication fork progression in human cells. Claspin has
repeatedly been proposed to play a role in monitoring
DNA replication for many reasons. Claspin binding to
chromatin is dependent on the pre-RC and Cdc45, which
is similar to the chromatin binding behavior of DNA
Figure 3. Replication fork rates in primary human skin fibroblasts
(1BR3) depleted of Claspin and Chk1. (A) Claspin, Chk1, and
XRCC1 (control) levels in total cell extract from 1BR3 cells treated
with luciferase (control), Chk1, or Claspin siRNA for 48 h. (B)
Distribution of replication fork rates in control- or Claspin-depleted
1BR3 cells pulse labeled and processed as described above. (C)
Distribution of replication fork rates in Chk1- or Claspin-depleted
1BR3 cells. For each panel, the distribution of fork rates during the
entire labeling period is shown. Data are combined from two inde-
pendent experiments. For each data set, the similar results were
observed in each experimental repeat. The total number of forks
scored for each cell line is indicated in parentheses.
Figure 4. Effects of Claspin depletion on Chk1 phosphorylation in
HeLa and HCT116 cells treated with the replication inhibitor hy-
droxyurea. HeLa cells (A) and HCT116 cells (B) were treated with
nontargeting siRNA pool or Claspin siRNA for 40 h, and then they
were treated or not with 10 mM HU for 1, 2, 4, and 6 h as indicated.
Claspin and Chk1 levels and phosphorylation of Chk1 on Ser317
and Ser345 were visualized using specific antibodies. Phosphory-
lated bands of Chk1 are denoted by arrows, and hyperphosphory-
lated bands are denoted by arrows with asterisks. Relative phos-
phorylated Chk1 levels were determined by densitometry and
normalized to total Chk1 levels. Subsequently, phosphorylated
Chk1 levels in Claspin-depleted cells were normalized to phosphor-
ylated Chk1 levels in control cells.
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polymerase  and which suggests binding during the
initial unwinding step (Lee et al., 2003). Depletion of
Claspin from Xenopus egg extracts decreases in vitro repli-
cation rates (Lee et al., 2003), and Mrc1, the functional
Claspin homologue in S. cerevisiae, is required for normal
fork progression rates (Szyjka et al., 2005; Tourriere et al.,
2005). Here we show that Claspin is indeed critical for
normal replication fork progression, suggesting that it acts
as a replication factor. This is the first demonstration of a
role for Claspin in maintaining normal fork rates in verte-
brate cells.
Claspin, as well as Chk1 depletion, affects replication fork
rates in a variety of human cell lines, including p53-deficient
and -proficient cells and primary fibroblasts (Figures 1–3).
The effect on replication fork rates in primary fibroblasts is
however small (Figure 3), and we speculate that the require-
ment for Claspin and Chk1 for normal fork progression is
more pronounced in fast-growing cell lines with high global
fork progression rates (1BR3 cells display relatively slow
mean fork rates; Table 1). Alternatively, this result could
reflect differences in depletion efficiency and basal Claspin
levels in the cell lines used. Interestingly, lack of Bloom
syndrome helicase (BLM) was recently reported to result in
slow fork progression. This replication slowing in BLM-
deficient cells was similar in primary and transformed fibro-
blasts, suggesting that BLM might fulfill a function that is
more routinely required during normal replication, in pri-
mary fibroblasts at least, than that fulfilled by Claspin and
Chk1 (Rao et al., 2007).
We demonstrated previously that Chk1 maintains high
rates of replication fork progression in HeLa and chicken
DT40 cells (Petermann et al., 2006). Subsequently, it was
shown that Chk1 is required for Claspin stability in HeLa
cells and that Claspin levels decrease after 72 h of Chk1
siRNA treatment (Chini et al., 2006). We therefore investi-
gated the possibility that the reduced fork speeds we ob-
served in Chk1-depleted HeLa cells might be due to lack of
Claspin. However, Chk1-depleted HeLa cells, as well as
HCT116 and 1BR3 cells, retain normal levels of Claspin
under our conditions, which include a maximal 48 h of
siRNA treatment (Figures 1–3). Reduced fork speeds in
Chk1-depleted cells are therefore not due absence of
Claspin.
We also considered the possibility that reduced fork rates
in Claspin-depleted cells reflect its role in facilitating ATR-
mediated phosphorylation of Chk1 at Ser317 and Ser345
(Kumagai and Dunphy, 2000; Chini and Chen, 2003; Chini
et al., 2006). Although we observed decreased Chk1 phos-
phorylation at Ser317 and Ser345 in Claspin-depleted cells,
significant residual phosphorylation did still occur, espe-
cially at Ser317 (Figure 4). This might be due to incomplete
depletion of Claspin, or to redundancy of Claspin with other
mediators of Chk1 phosphorylation such as BRCA1 (Lin
et al., 2004; Yoo et al., 2006). The more pronounced effect of
Claspin depletion on phosphorylation at Ser345 and hyper-
phosphorylation suggests that Claspin mainly facilitates ef-
ficient Chk1 phosphorylation at sites other than Ser317. Al-
though we cannot rule out that the partial reduction in Chk1
phosphorylation (50–70%) is sufficient to account for the
slower fork rates observed in Claspin-depleted cells, we
favor the possibility that Claspin fulfills one or more addi-
tional roles during the maintenance of normal fork rates. It
is also noteworthy in this respect that depletion of Chk1 and
Claspin together doubled the percentage of very slow forks
compared with depletion of each protein alone, supporting
the possibility that Claspin maintains normal fork rates
through mechanisms other than, or in addition to, Chk1
function (Figure 5). A similar phenomenon has been ob-
served in budding yeast, where the checkpoint function of
Mrc1 is not required for its role in normal replication fork
progression (Osborn and Elledge, 2003). Interestingly, high
Chk1 activity has been found to reduce rather than promote
replication fork progression (Seiler et al., 2007), whereas
Chk1 promotes fork rates in unperturbed cells when Chk1
phosphorylation and basal activity are low. These observa-
tions further support the idea that Claspin promotes fork
progression independently of Chk1 phosphorylation.
Figure 5. Comparison of replication fork
rates in HeLa cells depleted of both Claspin
and Chk1 and depleted of Claspin or Chk1
alone. (A) Claspin, Chk1 and XRCC1 (control)
levels in total cell extract from HeLa cells
treated with luciferase siRNA (control), Chk1
siRNA, Claspin siRNA, or both Claspin and
Chk1 siRNA for 24 h. Relative Claspin and
Chk1 levels were determined by densitometry
and normalized to levels in control cells. De-
pletion efficiencies are given for the blot
shown and as averages of all three indepen-
dent experiments. (B) Distribution of replica-
tion fork rates in Claspin and Chk1- or
Claspin alone-depleted HeLa cells processed
as in Figure 1. (C) Distribution of replication
fork rates in Claspin and Chk1- or Chk1 alone-
depleted HeLa cells. Data bars are the mean of
three independent experiments, with similar
results observed in each, and error bars rep-
resent 1 SD.
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What might be the mechanisms by which Claspin and
Chk1 facilitate replication fork progression? We previously
suggested a role for Chk1 in maintaining fork stability based
on the observation that Chk1 deficiency reduces fork rates
more strongly during the second pulse label, indicating
increased irreversible or prolonged fork stalling (Petermann
et al., 2006). Our current experiments did again show a
greater impact of Claspin or Chk1 depletion during the
second pulse label, although this effect was not equally
pronounced in all cell lines analyzed (data not shown).
Claspin might thus also facilitate replication fork progres-
sion by preventing prolonged fork stalling. Currently, we
cannot discriminate between an impact of Claspin on fork
stabilization, fork restart, or both. However, in budding
yeast, Mrc1 is not required to prevent fork collapse during
HU treatment, but for restart of stalled replication forks
(Tourriere et al., 2005). This suggests that Mrc1 acts together
with the replication machinery to facilitate proper replica-
tion fork progression, rather than facilitating the repair of
damaged replication forks. Claspin may play a similar role,
an idea that might be supported by the observation that
Claspin seems to bind chromatin during origin unwinding,
suggesting that it travels with all replication forks (Lee et al.,
2003, 2005).
In summary, we show here that Claspin is required to
maintain high rates of replication fork progression in human
cells during normal, unperturbed S phase. In addition, we
suggest that this requirement may extend beyond the role of
Claspin in mediating the phosphorylation of Chk1 at Ser317
and Ser345. Several human cancer cell lines overexpress
Claspin (Lin et al., 2004), and it is possible that the role of this
important protein in regulating replication fork rates may
impact greatly on genome stability.
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